Comparison of 5-fluoro-2′-deoxyuridine with 5-fluorouracil and their role in the treatment of colorectal cancer
- 1 February 1998
- journal article
- research article
- Published by Elsevier in European Journal Of Cancer
- Vol. 34 (3) , 296-306
- https://doi.org/10.1016/s0959-8049(97)00366-3
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- The effect of different routes of administration of 5-fluorouracil on thymidylate synthase inhibition in the ratEuropean Journal Of Cancer, 1995
- ‘Tomudex’ (ZD1694): Results of a randomised trial in advanced colorectal cancer demonstrate efficacy and reduced mucositis and leucopeniaEuropean Journal Of Cancer, 1995
- ZD1694 (Tomudex): A new thymidylate synthase inhibitor with activity in colorectal cancerEuropean Journal Of Cancer, 1995
- Chronomodulation of chemotherapy against metastatic colorectal cancerEuropean Journal Of Cancer, 1995
- CPT-11 (Irinotecan) in the treatment of colorectal cancerEuropean Journal Of Cancer, 1995
- Modulation of the antitumour activity of cisplatin alone and in combination with 5-fluoro-2'-deoxyuridine by N-phosphonacetyl-l-aspartate in murine colon carcinoma no. 26European Journal Of Cancer, 1995
- A role for dihydropyrimidine dehydrogenase and thymidylate synthase in tumour sensitivity to fluorouracilEuropean Journal Of Cancer, 1994
- Predictive value of thymidylate synthase and dihydropyrimidine dehydrogenaseEuropean Journal Of Cancer, 1994
- Changes in glycosylation of L1210 cells after exposure to various antimetabolitesEuropean Journal Of Cancer, 1993
- Fluorinated Pyrimidines, A New Class of Tumour-Inhibitory CompoundsNature, 1957